US Food and Drug Administration (FDA) has given approval to Nexus Pharmaceuticals for its Emerphed (ephedrine sulfate injection) in 25mg/5mL and 50mg/10mL single-dose pre-filled syringes.
LINCOLNSHIRE, Ill. (BUSINESS WIRE) #ANDA Nexus Pharmaceuticals, Inc. announced that it has received US Food and Drug Administration (FDA) approval for EMERPHED® (ephedrine sulfate injection) in 25mg/5mL and 50mg/10mL single-dose pre-filled syringes. The 10mL presentation is the first and only FDA-approved ready-t.